GENOVESE, Filippo
 Distribuzione geografica
Continente #
NA - Nord America 3.856
EU - Europa 3.657
AS - Asia 1.985
SA - Sud America 305
AF - Africa 35
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.843
Nazione #
US - Stati Uniti d'America 3.792
GB - Regno Unito 1.375
IT - Italia 940
SG - Singapore 632
CN - Cina 624
DE - Germania 330
HK - Hong Kong 263
BR - Brasile 256
SE - Svezia 240
FR - Francia 131
RU - Federazione Russa 128
VN - Vietnam 105
PL - Polonia 102
FI - Finlandia 81
UA - Ucraina 76
KR - Corea 63
TR - Turchia 58
JP - Giappone 57
IN - India 47
ID - Indonesia 39
NL - Olanda 38
CA - Canada 36
BG - Bulgaria 32
BE - Belgio 31
CH - Svizzera 27
IE - Irlanda 24
ES - Italia 20
LT - Lituania 19
MX - Messico 18
PK - Pakistan 18
AR - Argentina 16
AT - Austria 15
ZA - Sudafrica 14
BD - Bangladesh 13
CZ - Repubblica Ceca 10
DK - Danimarca 10
IQ - Iraq 10
MY - Malesia 8
PY - Paraguay 7
CO - Colombia 6
LI - Liechtenstein 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
IR - Iran 5
JO - Giordania 5
VE - Venezuela 5
BH - Bahrain 4
CR - Costa Rica 4
IL - Israele 4
NO - Norvegia 4
PE - Perù 4
SA - Arabia Saudita 4
TZ - Tanzania 4
CL - Cile 3
EG - Egitto 3
GR - Grecia 3
KZ - Kazakistan 3
MA - Marocco 3
TN - Tunisia 3
TW - Taiwan 3
UZ - Uzbekistan 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
AZ - Azerbaigian 2
GT - Guatemala 2
JM - Giamaica 2
KE - Kenya 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZW - Zimbabwe 1
Totale 9.843
Città #
Southend 1.170
Santa Clara 464
Ashburn 406
Singapore 375
Chandler 293
Fairfield 261
Hong Kong 258
Woodbridge 219
Hefei 202
Ann Arbor 185
Houston 164
Nyköping 138
Dearborn 135
Jacksonville 124
Frankfurt am Main 117
Wilmington 112
Modena 107
Cambridge 105
Seattle 95
Beijing 92
London 90
Kraków 77
New York 75
Los Angeles 72
Tokyo 55
Milan 49
Seoul 49
Shanghai 41
Helsinki 39
Munich 38
Bologna 34
Ho Chi Minh City 32
Moscow 32
Princeton 32
Sofia 32
Fremont 31
Jakarta 31
The Dalles 31
San Diego 29
Hanoi 28
Chicago 26
Eugene 26
Izmir 26
Rome 25
Buffalo 23
Dublin 22
Brussels 19
Redwood City 19
Warsaw 19
São Paulo 18
Boardman 17
Padova 17
Lahore 16
Orem 16
Parma 16
Council Bluffs 15
Dallas 15
Turku 15
San Gimignano 14
Stockholm 13
Bremen 12
Nuremberg 12
Reggio Emilia 12
Rio de Janeiro 12
Atlanta 11
Des Moines 11
Ferrara 11
Paris 11
Phoenix 11
Ravenna 11
Brno 10
Brooklyn 10
Naples 10
Amsterdam 9
Guangzhou 9
Johannesburg 9
Prato 9
Vienna 9
Charleston 8
Columbus 8
Jinan 8
Kent 8
Salt Lake City 8
Vicenza 8
Zurich 8
Calcinaia 7
Denver 7
Montreal 7
Ottawa 7
Rodano 7
Verona 7
Falls Church 6
Leuven 6
Messina 6
Perugia 6
Ripi 6
Sant'Ilario d'Enza 6
Shenzhen 6
Toronto 6
Berlin 5
Totale 6.636
Nome #
Oxytetracycline-Protein Complex: The Dark Side of Pet Food 733
Metodo per la funzionalizzazione sito specifica di molecole proteiche 401
Enamel peptides reveal the sex of the Late Antique ‘Lovers of Modena’ 393
An autoregulatory loop controls the expression of the transcription factor NF-Y 364
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 360
Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones? 346
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 336
Mass Spectrometric/Bioinformatic Identification of a Protein Subset That Characterizes the Cellular Activity of Anticancer Peptides 333
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 321
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 317
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer 305
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 301
Proteomic Approach to the Detection of the Mechanism of Action of Anticancer Peptides 299
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 297
Allosteric Inhibition of human Thymidylate Synthase. 297
A proteomic approach to investigate the mechanism of action of anticancer peptides 281
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 265
Design, synthesis and biological evaluation of non-covalent AmpC Beta-Lactamases inhibitors 246
Chairperson EUTROC- Mayo Conference-Berlin - Preliminary characterization of pharmacodynamic biomarkers for LR-peptide growth inhibition of ovarian cancer (OC) cell models. 242
pH sensitive PEGylated Liposomes delivering active hydrophilic peptide with anticancer activity: in vitro study on cDDP-resistant ovarian cell line 242
MALDI-TOF MS as a tool for rapid Identification of Low Protein Affinity Drug Fragments. 239
Invited lecture to 18th World Congress on Advances in Oncology and 16th International Symposium on Molecular Medicine 10-12 October, 2013, Creta Maris, Hersonissos, Crete, Greece 238
Discovery and preliminary characterization of a novel inhibitor of the SOS response in Pseudomonas aeruginosa 223
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 221
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 217
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 215
EVALUATION OF LR STABILITY BY LC CHIP Q-TOF AND QUANTITATIVE DETERMINATION OF LR PEPTIDE CELL PENETRATION BY LC-MS/MS 211
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 207
Merging disulphide bonds for drug design Interfering with a cancer key protein 201
A dual-Omics approach to identify the modulated proteins/genes in THP-1 cells infected with different drug resistant L. infantum clinical isolates. 177
LC-MS/MS Helps Characterizing THP-1 Cells Proteome After Infection with Drug Resistant Leishmania Strains 164
Development and validation of a new storage procedure to extend the in-use stability of azacitidine in pharmaceutical formulations 162
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 143
LC-MS/MS proteomics for the rapid and selective screening of drug resistances in Leishmania infantum clinical isolates 138
Label-Free Mass Spectrometry Proteomics Reveals Different Pathways Modulated in THP-1 Cells Infected with Therapeutic Failure and Drug Resistance Leishmania infantum Clinical Isolates 135
Insights into host-target interaction from the proteome modulation analysis through untargeted LC-MS/MS Proteomics of drug resistant L infantum-THP1 infected cells 132
Deciphering Host–Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance 130
Quantitative comparison of the protein corona of nanoparticles with different matrices 102
Totale 9.934
Categoria #
all - tutte 31.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021814 0 0 0 0 0 112 125 125 69 257 79 47
2021/2022681 39 82 41 43 27 48 56 38 60 40 120 87
2022/2023920 95 121 60 91 81 122 43 120 71 13 56 47
2023/2024937 33 39 44 73 232 74 156 88 23 26 59 90
2024/20252.103 80 29 75 160 386 281 183 128 196 83 223 279
2025/20261.776 243 145 227 377 554 230 0 0 0 0 0 0
Totale 9.934